Genomma Lab Internacional
Genomma Lab Internacional (ticker: LAB B) is a Mexican health‑care company that develops, markets, sells, and distributes over‑the‑counter drugs and personal‑care products. The company is listed on the Mexican Stock Exchange under the symbol LAB B.
Recent Trading Activity
- Price at 10:50 PM CET (Thursday 22 Oct 2026): MXN 14.69
- Change in the last 24 h: +0.98 %
- Volume traded: MXN 57.9 million
- Market capitalization: MXN 13.9 bn
- Shares outstanding: 974.7 million
- 14‑month change: +14.95 %
- 200‑day simple moving average: MXN 15.61
- 52‑week high: MXN 19.48 (21 Apr 2026)
- 52‑week low: MXN 12.22 (21 Sep 2026)
Latest Financial Update
Genomma Lab Internacional released its third‑quarter 2026 earnings report on 22 Oct 2026. Key points from the report:
| Metric | Result |
|---|---|
| Sales growth (Mexico & Latin America) | Modest increase |
| Product launch impact | Significant sell‑out lift at key retail accounts |
| Market share for flagship brand | Increase |
| EBITDA margin | Aligned with expectations |
| Net income | Up, driven by lower financing costs and favorable FX movements |
| Promotion & commercial investment | Increased to accelerate growth |
| Management outlook | Confident in operating plan; upcoming New‑York presentation on an AI platform for future execution |
The company’s shares continue to receive analyst coverage and maintain a stable position in the Mexican equity market.
Peer Performance (last 24 h)
| Stock | Ticker | Current Price | Market Cap | P/E Ratio | 24‑h Change |
|---|---|---|---|---|---|
| Grupo Palacio de Hierro | GPH1.MX | MXN 42 | MXN 15.9 bn | 5.59 | 0 % |
| Grupo Posadas Sab de Cv | POSADASA.MX | MXN 27 | MXN 13.4 bn | 125.46 | 0 % |
| Betterware de Mexico S.A. de | BWMX | USD 15.98 | USD 588.5 mn | 7.73 | –1.43 % |
| Cydsa Sab de Cv | CYDSASAA.MX | MXN 27 | MXN 14 bn | 20.76 | +0.11 % |
| Value Grupo Financiero Sab D | VALUEGFO.MX | MXN 60 | MXN 9.6 bn | – | 0 % |
On 22 Oct 2026, Value Grupo Financiero SAB announced a public offering of American‑style call options on three underlying equities (SK Hynix, GE Vernova, NVIDIA). The options were issued in Mexico with settlement in pesos and fully funded by the issuer’s resources.
Company Profile
Genomma Lab Internacional SAB de CV is headquartered in Mexico City. The company operates in the health‑care sector, focusing on the development, marketing, and distribution of over‑the‑counter pharmaceuticals and personal‑care products.
